Zhende Medical Co., Ltd. (603301.SS)
CNY 19.14
(-0.05%)
CNY 19.14
(-0.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 225.94 Million CNY | -72.2% |
| 2022 | 812.8 Million CNY | -1.11% |
| 2021 | 821.97 Million CNY | -76.76% |
| 2020 | 3.53 Billion CNY | 1665.56% |
| 2019 | 200.33 Million CNY | 30.58% |
| 2018 | 153.41 Million CNY | 3.66% |
| 2017 | 148 Million CNY | 86.93% |
| 2016 | 79.17 Million CNY | -4.02% |
| 2015 | 82.49 Million CNY | 405.37% |
| 2014 | 16.32 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 101.86 Million CNY | 89.02% |
| 2024 Q1 | 85.77 Million CNY | 181.23% |
| 2024 Q2 | 102.96 Million CNY | 20.04% |
| 2023 Q3 | 67.43 Million CNY | -25.39% |
| 2023 FY | 225.94 Million CNY | -72.2% |
| 2023 Q1 | 173.71 Million CNY | -41.22% |
| 2023 Q2 | 90.38 Million CNY | -47.97% |
| 2023 Q4 | -105.59 Million CNY | -256.58% |
| 2022 FY | 812.8 Million CNY | -1.11% |
| 2022 Q3 | 202.89 Million CNY | 15.94% |
| 2022 Q4 | 295.52 Million CNY | 45.65% |
| 2022 Q2 | 175 Million CNY | 25.56% |
| 2022 Q1 | 139.38 Million CNY | -9.07% |
| 2021 FY | 821.97 Million CNY | -76.76% |
| 2021 Q3 | 145.84 Million CNY | -8.22% |
| 2021 Q4 | 153.28 Million CNY | 5.1% |
| 2021 Q1 | 363.94 Million CNY | -42.88% |
| 2021 Q2 | 158.9 Million CNY | -56.34% |
| 2020 Q4 | 637.18 Million CNY | -59.64% |
| 2020 FY | 3.53 Billion CNY | 1665.56% |
| 2020 Q1 | 104.54 Million CNY | 32.47% |
| 2020 Q2 | 1.21 Billion CNY | 1063.53% |
| 2020 Q3 | 1.57 Billion CNY | 29.79% |
| 2019 FY | 200.33 Million CNY | 30.58% |
| 2019 Q4 | 78.92 Million CNY | 63.19% |
| 2019 Q3 | 48.36 Million CNY | 27.83% |
| 2019 Q2 | 37.83 Million CNY | 7.43% |
| 2019 Q1 | 35.21 Million CNY | -32.79% |
| 2018 Q4 | 52.39 Million CNY | 37.23% |
| 2018 FY | 153.41 Million CNY | 3.66% |
| 2018 Q1 | 24.04 Million CNY | -59.47% |
| 2018 Q2 | 38.79 Million CNY | 61.37% |
| 2018 Q3 | 38.18 Million CNY | -1.59% |
| 2017 Q2 | 29.3 Million CNY | 11.82% |
| 2017 Q1 | 26.21 Million CNY | 0.0% |
| 2017 FY | 148 Million CNY | 86.93% |
| 2017 Q3 | 32.99 Million CNY | 12.59% |
| 2017 Q4 | 59.31 Million CNY | 79.77% |
| 2016 FY | 79.17 Million CNY | -4.02% |
| 2015 FY | 82.49 Million CNY | 405.37% |
| 2014 FY | 16.32 Million CNY | 0.0% |